These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10171477)

  • 41. Is corporate influence good for medicine?
    Pontious JM
    J Okla State Med Assoc; 2004 Mar; 97(3):104. PubMed ID: 15088812
    [No Abstract]   [Full Text] [Related]  

  • 42. [Is accepting an invitation to a conference on Hawaii unethical?].
    Andrén-Sandberg A
    Lakartidningen; 2005 Apr 4-10; 102(14):1057-8, 1060. PubMed ID: 15892476
    [No Abstract]   [Full Text] [Related]  

  • 43. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure.
    Hensley S
    Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117
    [No Abstract]   [Full Text] [Related]  

  • 44. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
    Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
    [No Abstract]   [Full Text] [Related]  

  • 45. Prescription for conflict. AMA accepts funding from drug firms for campaign.
    Romano M
    Mod Healthc; 2001 Jun; 31(25):14. PubMed ID: 11436381
    [No Abstract]   [Full Text] [Related]  

  • 46. Guidelines for collaboration of industry and surgical organizations in support of research and continuing education.
    Committee on Ethics, American College of Surgeons
    Bull Am Coll Surg; 2001 May; 86(5):30-1. PubMed ID: 12298364
    [No Abstract]   [Full Text] [Related]  

  • 47. Indirect payments from drug companies to doctors for CME courses will be exempt from database.
    Hawkes N
    BMJ; 2014 Nov; 349():g6676. PubMed ID: 25378344
    [No Abstract]   [Full Text] [Related]  

  • 48. Two views on funding. Drug firm's financial support of AMA ethics campaign poses a debate.
    Romano M
    Mod Healthc; 2001 Apr; 31(17):12. PubMed ID: 11338891
    [No Abstract]   [Full Text] [Related]  

  • 49. Commercial support for continuing medical education.
    Mamdani MB; Mamdani B
    Issues Med Ethics; 1997; 5(2):43-5. PubMed ID: 16267900
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug company sponsorship of education could be replaced at a fraction of its cost.
    Moynihan R
    BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595
    [No Abstract]   [Full Text] [Related]  

  • 51. Continuing medical education. Unabated debate.
    Wentz DK; Osteen AM; Cannon MI
    JAMA; 1992 Sep; 268(9):1118-20. PubMed ID: 1501334
    [No Abstract]   [Full Text] [Related]  

  • 52. Pushing drugs to doctors.
    Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
    [No Abstract]   [Full Text] [Related]  

  • 53. Continuing medical education: comment on "clinician attitudes about commercial support of continuing medical education".
    Dorman T; Silver IL
    Arch Intern Med; 2011 May; 171(9):847-8. PubMed ID: 21555663
    [No Abstract]   [Full Text] [Related]  

  • 54. When names make claims: ethical issues in medical device marketing.
    Bramstedt KA
    Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483
    [No Abstract]   [Full Text] [Related]  

  • 55. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceutical industry-sponsored meetings: good value or just a free meal?
    Carney SL; Nair KR; Sales MA; Walsh J
    Intern Med J; 2001 Nov; 31(8):488-91. PubMed ID: 11720063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. US accrediting agency tightens rules for continuing medical education.
    Tanne JH
    BMJ; 2004 Oct; 329(7470):819. PubMed ID: 15472255
    [No Abstract]   [Full Text] [Related]  

  • 58. Crackdown urged on doc gifts.
    Robeznieks A
    Mod Healthc; 2008 May; 38(18):20. PubMed ID: 18557478
    [No Abstract]   [Full Text] [Related]  

  • 59. Sounding Boards. The support of continuing medical education by pharmaceutical companies.
    Kaplan NM
    N Engl J Med; 1979 Jan; 300(4):194-6. PubMed ID: 759847
    [No Abstract]   [Full Text] [Related]  

  • 60. Questionnaire survey on sponsorship of Continuing Medical Education program by pharmaceutical companies.
    Jain MM; Khatib SA; Shenoi A
    Indian Pediatr; 2000 Feb; 37(2):190-2. PubMed ID: 10745416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.